CA2260397A1 - Method of converting rendered triglyceride oil from marine sources into bland, stable food oil - Google Patents

Method of converting rendered triglyceride oil from marine sources into bland, stable food oil Download PDF

Info

Publication number
CA2260397A1
CA2260397A1 CA002260397A CA2260397A CA2260397A1 CA 2260397 A1 CA2260397 A1 CA 2260397A1 CA 002260397 A CA002260397 A CA 002260397A CA 2260397 A CA2260397 A CA 2260397A CA 2260397 A1 CA2260397 A1 CA 2260397A1
Authority
CA
Canada
Prior art keywords
oil
omega
fatty acids
seal
refined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002260397A
Other languages
English (en)
French (fr)
Inventor
Ted Mag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atlantis Marine Inc
Original Assignee
Atlantis Marine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atlantis Marine Inc filed Critical Atlantis Marine Inc
Priority to CA002260397A priority Critical patent/CA2260397A1/en
Priority to EP00901447A priority patent/EP1151067A1/en
Priority to CA002346407A priority patent/CA2346407C/en
Priority to JP2000596107A priority patent/JP2002540221A/ja
Priority to AU22736/00A priority patent/AU2273600A/en
Priority to US09/890,383 priority patent/US7179491B1/en
Priority to PCT/CA2000/000078 priority patent/WO2000044862A1/en
Publication of CA2260397A1 publication Critical patent/CA2260397A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/10—Refining fats or fatty oils by adsorption
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/16—Fatty acid esters
    • A21D2/165—Triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/001—Refining fats or fatty oils by a combination of two or more of the means hereafter

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
CA002260397A 1999-01-29 1999-01-29 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil Abandoned CA2260397A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA002260397A CA2260397A1 (en) 1999-01-29 1999-01-29 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil
EP00901447A EP1151067A1 (en) 1999-01-29 2000-01-28 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
CA002346407A CA2346407C (en) 1999-01-29 2000-01-28 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
JP2000596107A JP2002540221A (ja) 1999-01-29 2000-01-28 海洋源からの精製されたトリグリセリドを、穏やかな安定性油に変換するプロセス
AU22736/00A AU2273600A (en) 1999-01-29 2000-01-28 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
US09/890,383 US7179491B1 (en) 1999-01-29 2000-01-28 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
PCT/CA2000/000078 WO2000044862A1 (en) 1999-01-29 2000-01-28 Process of converting rendered triglyceride oil from marine sources into bland, stable oil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002260397A CA2260397A1 (en) 1999-01-29 1999-01-29 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil

Publications (1)

Publication Number Publication Date
CA2260397A1 true CA2260397A1 (en) 2000-07-29

Family

ID=4163238

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002260397A Abandoned CA2260397A1 (en) 1999-01-29 1999-01-29 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil

Country Status (6)

Country Link
US (1) US7179491B1 (enExample)
EP (1) EP1151067A1 (enExample)
JP (1) JP2002540221A (enExample)
AU (1) AU2273600A (enExample)
CA (1) CA2260397A1 (enExample)
WO (1) WO2000044862A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179491B1 (en) 1999-01-29 2007-02-20 Ted Mag Process of converting rendered triglyceride oil from marine sources into bland, stable oil
US7678930B2 (en) 2002-07-11 2010-03-16 Pronova Biopharma Norge As Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
US7718698B2 (en) 2002-07-11 2010-05-18 Pronova Biopharma Norge As Process for decreasing environmental pollutants in an oil or a fat

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1304406B1 (it) * 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
PT102509A (pt) * 2000-08-16 2002-02-28 Fundacao Essprit Icarus Composicoes farmaceuticas, cosmeticas e dermo-cosmeticas, de higiene, alimentares e para-alimentares a base de oleo de foca, e sua utilizacao
JP5000035B2 (ja) * 2000-09-04 2012-08-15 株式会社スピルリナ研究所 ドコサペンタエン酸含有グリセリドの製造方法
DE10196619D2 (en) * 2001-07-05 2004-05-06 Hans-Werner Luedke Nahrungsergänzungsprodukt oder arzneimittel gegen bestimmte mangelzustände und hirnfunktionsstörungen
EP1417211B1 (en) 2001-07-27 2007-05-30 Neptune Technologies & Bioressources Inc. Natural phospholipids of marine origin containing flavonoids and polyunsaturated phospholipids and their uses
CN1620253A (zh) * 2001-12-27 2005-05-25 创世纪集团公司 海豹油基脂质乳液及其用途
ES2391381T3 (es) * 2002-05-03 2012-11-23 Martek Biosciences Corporation Lípidos de alta calidad y métodos para su producción mediante liberación enzimática a partir de biomasa
AU2003270909A1 (en) * 2002-09-27 2004-04-19 Martek Biosciences Corporation Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
EP2384750A1 (en) * 2002-09-27 2011-11-09 Martek Biosciences Corporation Improved Glycemic Control for Prediabetes and/or Diabetes Type II using Docohexaenoic Acid
AU2004268196B2 (en) 2003-08-21 2010-03-04 Monsanto Technology Llc Fatty acid desaturases from primula
JP4699901B2 (ja) * 2003-09-02 2011-06-15 ジェレックスインターナショナル株式会社 体脂肪代謝機能と燃焼エネルギーの活用機能とを備えているダイエット用添加物質
ITMI20032247A1 (it) 2003-11-19 2005-05-20 Tiberio Bruzzese Interazione di derivati polari di composti insaturi con substrati inorganici
JP2007533310A (ja) 2004-04-16 2007-11-22 モンサント テクノロジー エルエルシー トウモロコシにおける脂肪酸デサチュラーゼの発現
EP2218334B1 (en) 2004-11-04 2016-09-28 Monsanto Technology LLC Processes for preparation of oil compositions
US7977498B2 (en) 2005-08-26 2011-07-12 Ocean Nutrition Canada Limited Reduction of sterols and other compounds from oils
PE20070482A1 (es) * 2005-08-26 2007-06-08 Ocean Nutrition Canada Ltd Metodo para remover y/o reducir esteroles a partir de aceites
EP1928917A2 (en) * 2005-09-09 2008-06-11 Kellogg Company Omega-3 fatty acids encapsulated in zein coatings and food products incorporating the same
US7867538B2 (en) 2005-12-20 2011-01-11 Archer Daniels Midland Company Processes of improving the quality of oil and products produced therefrom
BR122018075948B1 (pt) 2006-03-10 2023-05-16 Monsanto Technology Llc Métodos de produzir uma planta de soja com teor de ácidos graxos de semente alterados
TW200820913A (en) * 2006-08-25 2008-05-16 Martek Biosciences Corp Food fortification with polyunsaturated fatty acids
US20090162525A1 (en) * 2007-12-21 2009-06-25 Tropicana Products, Inc. Food product including one or more encapsulated omega-3 fatty acids and one or more fruit flavors
WO2009102558A2 (en) * 2008-02-11 2009-08-20 Monsanto Technology Llc Aquaculture feed, products, and methods comprising beneficial fatty acids
WO2009132463A1 (en) * 2008-05-02 2009-11-05 Neptune Technologies & Bioressources Inc. New deodorization method and organoleptic improvement of marine oil extracts
CA2742227C (en) * 2008-10-31 2017-01-24 Lipid Pharmaceuticals Ehf. The use of fatty acid compositions as laxatives
DE102008060059A1 (de) * 2008-12-02 2010-06-10 Süd-Chemie AG Verfahren zur Reduzierung des 3-MCPD-Gehalts in raffinierten Pflanzenölen
CN102458109B (zh) 2009-04-29 2015-02-11 阿马里纳制药公司 稳定的药物组合物和使用其的方法
MX2011011517A (es) 2009-04-29 2012-06-19 Amarin Corp Plc Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
LT2443246T (lt) 2009-06-15 2018-03-26 Amarin Pharmaceuticals Ireland Limited Kompozicijos ir būdai, skirti trigliceridų sumažinimui, nepakeliant ldl-c lygio subjekte, kartu taikant statino terapiją
US9480271B2 (en) 2009-09-15 2016-11-01 Monsanto Technology Llc Soybean seed and oil compositions and methods of making same
US20110071176A1 (en) 2009-09-23 2011-03-24 Amarin Pharma, Inc. Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
JP5827625B2 (ja) 2009-10-29 2015-12-02 アカスティ ファーマ インコーポレイテッド 濃縮治療用リン脂質組成物
EP2366766B8 (en) * 2010-03-09 2017-04-19 Stepan Specialty Products, LLC Method of treating an edible oil and oil thus obtained
US11400058B2 (en) 2010-03-12 2022-08-02 Berg Llc Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof
EP2576801B1 (en) 2010-06-01 2019-10-02 DSM IP Assets B.V. Extraction of lipid from cells and products therefrom
AU2011336856A1 (en) 2010-11-29 2013-07-04 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
EA201490047A1 (ru) 2011-06-17 2014-08-29 Берг Ллк Ингаляционные фармацевтические композиции
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013103958A1 (en) 2012-01-06 2013-07-11 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
BR112014032905B1 (pt) 2012-06-29 2022-02-22 Amarin Pharmaceuticals Ireland Limited Uso de éster etílico do ácido eicosapentaenóico para redução do risco de morte cardiovascular, revascularização coronária e/ou angina instável em um indivíduo em terapia com estatina
ES2641451T3 (es) * 2012-07-31 2017-11-10 Dsm Nutritional Products Ag Refinado de aceites utilizando antioxidantes de extracto de té verde
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
ES2753387T3 (es) 2013-04-22 2020-04-08 Smartfish As Uso de una composición que comprende aceite de pescado y zumo para el tratamiento y/o tratamiento posterior del cáncer
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
CN103881801A (zh) * 2013-10-27 2014-06-25 刘跃 取消精炼工序并能有效降低食用油中水分的方法
WO2015095696A1 (en) 2013-12-20 2015-06-25 Dsm Ip Assets B.V. Processes for obtaining microbial oil from microbial cells
AU2014369042B2 (en) 2013-12-20 2020-04-30 Dsm Ip Assets B.V. Processes for obtaining microbial oil from microbial cells
JP2017500037A (ja) 2013-12-20 2017-01-05 ディーエスエム アイピー アセッツ ビー．ブイ． 微生物細胞から微生物油を入手するための方法
AR098893A1 (es) 2013-12-20 2016-06-22 Dsm Ip Assets Bv Proceso para obtener aceite microbiano a partir de células microbianas
BR112016014517B1 (pt) 2013-12-20 2022-06-28 Dsm Ip Assets B.V. Processo para a obtenção de um óleo microbiano compreendendo um ou mais ácidos graxos poli-insaturados de uma ou mais células microbianas
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
JP6967334B2 (ja) * 2015-12-21 2021-11-17 備前化成株式会社 高度不飽和脂肪酸のエステルを含む組成物
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
CN107746747A (zh) * 2017-11-08 2018-03-02 厦门汇盛生物有限公司 一种降低多不饱和脂肪酸油过氧化值和茴香胺值的方法
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
MA51766A (fr) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ie Ltd Procédés de réduction du risque d'événements cardiovasculaires chez un sujet
WO2020123965A1 (en) * 2018-12-14 2020-06-18 Dsm Ip Assets B.V. Polyunsaturated fatty acid containing food ingredient with enhanced palatabilty and method for manufacturing the same
CN114980973A (zh) 2019-11-12 2022-08-30 阿马里纳药物爱尔兰有限公司 降低心房纤颤和/或心房扑动受试者心血管事件风险的方法
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure
EP4586824A1 (en) * 2022-09-14 2025-07-23 Société des Produits Nestlé S.A. Compositions and methods utilizing southern ocean mackerel oil for providing health benefits in an animal
WO2025145410A1 (en) * 2024-01-05 2025-07-10 Cargill, Incorporated Methods of refining liquid oil and controlling p-anisidine value

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1564402A (en) * 1975-11-13 1980-04-10 Unilever Ltd Purification process
JPS58194994A (ja) 1982-05-10 1983-11-14 リノ−ル油脂株式会社 粗製グリセリド油組成物の精製方法
JPS59176264A (ja) 1983-03-04 1984-10-05 Itochu Shiryo Kk 生理活性物質
JPS6023493A (ja) 1983-07-18 1985-02-06 高尾　正保 精製魚油の製法
US4734226A (en) 1986-01-28 1988-03-29 W. R. Grace & Co. Method for refining glyceride oils using acid-treated amorphous silica
US4629588A (en) 1984-12-07 1986-12-16 W. R. Grace & Co. Method for refining glyceride oils using amorphous silica
US4880574A (en) 1984-12-07 1989-11-14 W. R. Grace & Co.-Conn. Method for refining glyceride oils using partially dried amorphous silica hydrogels
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
JPS6293234A (ja) 1985-10-21 1987-04-28 Terumo Corp 精製された魚油およびその製造方法
US5336794A (en) * 1986-05-14 1994-08-09 W. R. Grace & Co.-Conn. Dual phase adsorption and treatment of glyceride oils
ATE69975T1 (de) 1986-11-24 1991-12-15 Unilever Nv Metall-oxid-siliziumdioxid enthaltendes sorbentmittel und dessen verwendung zur oelraffinierung.
DE3643848A1 (de) 1986-12-22 1988-09-01 Natec Inst Naturwiss Verfahren zur herstellung hochraffinierter essbarer glyceridoele mit einem anteil an ungesaettigten fettsaeuren im triglyceridverband und ihre verwendung
IT1205043B (it) 1987-05-28 1989-03-10 Innova Di Ridolfi Flora & C S Procedimento per l'estrazione di esteri di acidi grassi poliinsaturi da olii di pesce e composizioni farmaceutiche e dietetiche contenenti detti esteri
US4780309A (en) * 1987-06-16 1988-10-25 Warner-Lambert Company Edible aerosol foam compositions and method of preparing same
US4874629A (en) 1988-05-02 1989-10-17 Chang Stephen S Purification of fish oil
US5264597A (en) 1988-09-30 1993-11-23 Van Den Bergh Foods, Co., Division Of Conopco, Inc. Process for refining glyceride oil using precipitated silica
US5012761A (en) 1988-11-17 1991-05-07 Oh Suk Y Chicken egg having relatively high percentage of long chain fatty acids and method of reducing heart related disease in humans using such eggs
US5079208A (en) 1988-12-30 1992-01-07 Van Den Bergh Foods Co., Division Of Conopco, Inc. Synthetic, macroporous, amorphous alumina silica and a process for refining glyceride oil
GB8906443D0 (en) * 1989-03-21 1989-05-04 Unilever Plc Process for refining glyceride oil using silica hydrogel
US5053169A (en) 1989-08-08 1991-10-01 W. R. Grace & Co.-Conn. Method for refining wax esters using amorphous silica
US5149851A (en) 1990-10-25 1992-09-22 The United States Of America As Represented By The Secretary Of Commerce Process for preparing triglycerides containing polyunsaturated fatty acid moieties
US5855944A (en) 1991-11-15 1999-01-05 Roche Vitamins Inc. Stabilization of marine oils
EP0612346B1 (en) * 1991-11-15 1995-06-14 F. Hoffmann-La Roche Ag Stabilization of marine oils
US5298638A (en) * 1992-05-05 1994-03-29 W. R. Grace & Co.-Conn. Adsorptive removal of sulfur compounds from fatty materials
JPH06116585A (ja) 1992-10-09 1994-04-26 Kanegafuchi Chem Ind Co Ltd 油脂の精製方法
JPH06181725A (ja) * 1992-12-17 1994-07-05 Kiteii:Kk 易酸化性油状物の固形化剤
JPH07203845A (ja) * 1994-01-14 1995-08-08 Nippon Synthetic Chem Ind Co Ltd:The 油脂の味覚改良方法
US5693835A (en) 1994-01-27 1997-12-02 Snow Brand Milk Products Co., Ltd. Fish oil having decreased fish odor and a method for preparing the same
US5720980A (en) 1994-02-23 1998-02-24 Bar-Kan University Plant protection using fish oil
DE69417726T2 (de) * 1994-05-09 1999-08-19 Societe Des Produits Nestle S.A. Verfahren zur Herstellung eines Konzentrates von Estern von mehrfach ungesättigten Fettsäuren
WO1996028150A1 (en) 1995-02-20 1996-09-19 Marit Eriksen Therapeutic skin cream
JP2815562B2 (ja) 1995-11-13 1998-10-27 植田製油株式会社 高度不飽和脂肪酸含有油脂の精製方法
KR100239179B1 (ko) * 1997-08-11 2000-01-15 원철희 밀랍의 제조방법
CA2260397A1 (en) 1999-01-29 2000-07-29 Atlantis Marine Inc. Method of converting rendered triglyceride oil from marine sources into bland, stable food oil

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179491B1 (en) 1999-01-29 2007-02-20 Ted Mag Process of converting rendered triglyceride oil from marine sources into bland, stable oil
US7678930B2 (en) 2002-07-11 2010-03-16 Pronova Biopharma Norge As Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
US7718698B2 (en) 2002-07-11 2010-05-18 Pronova Biopharma Norge As Process for decreasing environmental pollutants in an oil or a fat
US7732488B2 (en) 2002-07-11 2010-06-08 Pronova Biopharma Norge As Pharmaceutical composition comprising low concentrations of environmental pollutants

Also Published As

Publication number Publication date
EP1151067A1 (en) 2001-11-07
US7179491B1 (en) 2007-02-20
WO2000044862A1 (en) 2000-08-03
JP2002540221A (ja) 2002-11-26
AU2273600A (en) 2000-08-18

Similar Documents

Publication Publication Date Title
US7179491B1 (en) Process of converting rendered triglyceride oil from marine sources into bland, stable oil
Haq et al. Quality properties and bio-potentiality of edible oils from Atlantic salmon by-products extracted by supercritial carbon dioxide and conventional methods
EP0782827B1 (en) Use of a balancing agent for omega-6 and omega-3 unsaturated fatty acids
EP2429317B1 (en) Compositions rich in omega-3 fatty acids with a low content in phytanic acid
JP2002540221A5 (enExample)
SG177706A1 (en) A deodorized edible oil or fat with low levels of bound mcpd and process of making by carboxymethyl cellulose and/or resin purification
Maqsood et al. Extraction, processing, and stabilization of health-promoting fish oils
CA2694054A1 (en) Omega-3 fatty acid fortified composition
JP2014128273A (ja) 海産物油の脱臭および安定化
US9273267B2 (en) Method of treating an edible oil
CN1871331B (zh) 对多不饱和脂肪酸(pufa)酯浓缩物的稳定方法
KR101045397B1 (ko) 오메가-3 지방산 함량이 높은 정제 오징어유의 제조방법
US6428461B1 (en) Method for inhibiting oxidation of polyunsaturated lipids
MEYER et al. Fate of the synergistic antioxidant system ascorbic acid, lecithin, and tocopherol in mayonnaise: partition of ascorbic acid
CA2346407C (en) Process of converting rendered triglyceride oil from marine sources into bland, stable oil
JPS58849A (ja) 新規な食用油および油性栄養食品
JPS6170958A (ja) Ｅｐａ強化食品
Shahidi et al. Importance of non-triacylglycerols to flavor quality of edible oils
CN111107755A (zh) 婴儿食品产品
Shahidi QUALITY CHARACTERISTICS
WO2020236075A1 (en) Increasing stability of lc-pufa
Orders Fate of Omega-3 Fatty Acids from Algae in Mozzarella Cheese
KR20210081388A (ko) 향상된 산화 안정성을 나타내는 조성물
Ashokrao Oxidative Stability of Butter Supplemented with Docosahexaenoic Acid (DHA).

Legal Events

Date Code Title Description
FZDE Discontinued